Alcon AG (ALC)
SIX Swiss Exchange · Switzerland · prices in CHF · close of 23 Oct 2026
Key indicators
| Last close | CHF 57.94 |
|---|---|
| 52-week range | 47.80 – 68.34 |
| Return, 1 month / 3 months | +7.3% / +5.9% |
| Return, 1 year / 3 years | −4.5% / −9.6% |
| Trend | Uptrend |
| RSI (14) | 68 |
| Volatility (1 year) | 26.9% |
| Worst drawdown (1 year) | -27.0% |
| Average daily value traded | 59.85M CHF |
| Dividend yield | 0.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Alcon is an eye care company based in Switzerland that develops products for vision and eye health. It makes surgical equipment and devices used by eye surgeons for procedures such as cataract and retinal surgery, and it supplies intraocular lenses. The company also produces contact lenses and contact lens care products, along with prescription and over-the-counter eye drops and other medicines for conditions affecting the eye. Its customers include eye care professionals, hospitals, surgical centres and consumers around the world.
Alcon AG trades under the code ALC on the SIX Swiss Exchange in Switzerland, with its price quoted in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Alcon AG (ALC) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 57.94 on 23 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 121 of 226 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 4.5% and over the last three months it rose 5.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 43 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 0.9% | ||
| From 52-week high | -13.6% | ||
| Momentum | 43 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 5.9% | ||
| 6-month return | -2.8% | ||
| 12-month return, skipping the last month | -10.9% | ||
| Stability (higher is calmer) | 49 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 26.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.0% | ||
| Liquidity | 94 · Strong | Trades actively. | |
| Average daily value traded | 59.85M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | 31 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.5% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +5.8% |
|---|---|
| 1 month | +7.3% |
| 3 months | +5.9% |
| 6 months | −2.8% |
| 1 year | −4.5% |
| 3 years | −9.6% |
| 5 years | −21.3% |
Signals
| 50-day / 200-day average | 55.62 / 57.43 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.20 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 May 2026 | CHF 0.2800 |
| 13 May 2025 | CHF 0.2800 |
| 14 May 2024 | CHF 0.2400 |
| 10 May 2023 | CHF 0.2100 |
| 3 May 2022 | CHF 0.2000 |
| 4 May 2021 | CHF 0.1000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.